CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
NB-UVB Phototherapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02552316
NCT02552316N/ACompleted

The Cutaneous Microbiota of Psoriasis: Lesional Variation and a Phase IV, Interventional Study of Its Response to Phototherapy

University of Pennsylvania·interventional·Posted Sep 17, 2015·Updated Dec 2, 2020

In Brief

A clinical study evaluating NB-UVB Phototherapy for Psoriasis. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The ASPIRE study is a clinical trial designed to examine the microbes (e.g., bacteria) within psoriasis skin lesions compared with normal skin. The investigators will also examine the effect of NB-UVB (narrow-band ultraviolet B) phototherapy (i.e., light therapy) on skin microbes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsPfizer

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 17, 2015
Enrollment StartDec 1, 2014
Primary CompletionOct 1, 2019
Study CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 10.8 years ago

Interventions

NB-UVB Phototherapydevice